JP2024511163A5 - - Google Patents
Info
- Publication number
- JP2024511163A5 JP2024511163A5 JP2023558765A JP2023558765A JP2024511163A5 JP 2024511163 A5 JP2024511163 A5 JP 2024511163A5 JP 2023558765 A JP2023558765 A JP 2023558765A JP 2023558765 A JP2023558765 A JP 2023558765A JP 2024511163 A5 JP2024511163 A5 JP 2024511163A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- adenosine deaminase
- modifications
- group
- modification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163166778P | 2021-03-26 | 2021-03-26 | |
| US63/166,778 | 2021-03-26 | ||
| US202163229057P | 2021-08-03 | 2021-08-03 | |
| US63/229,057 | 2021-08-03 | ||
| PCT/US2022/022050 WO2022204574A1 (en) | 2021-03-26 | 2022-03-25 | Adenosine deaminase variants and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511163A JP2024511163A (ja) | 2024-03-12 |
| JP2024511163A5 true JP2024511163A5 (cg-RX-API-DMAC7.html) | 2025-04-01 |
Family
ID=83397962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558765A Pending JP2024511163A (ja) | 2021-03-26 | 2022-03-25 | アデノシンデアミナーゼバリアント及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240158775A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4313118A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024511163A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240004276A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022246176A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023019539A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3214494A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022204574A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3850088A4 (en) | 2018-09-07 | 2023-07-19 | Beam Therapeutics, Inc. | Compositions and methods for improving base editing |
| KR20210055733A (ko) | 2018-09-07 | 2021-05-17 | 빔 테라퓨틱스, 인크. | 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법 |
| JP7646552B2 (ja) | 2019-01-31 | 2025-03-17 | ビーム セラピューティクス インク. | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ |
| US12600971B2 (en) | 2019-02-13 | 2026-04-14 | Beam Therapeutics Inc. | Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence |
| WO2020168135A1 (en) | 2019-02-13 | 2020-08-20 | Beam Therapeutics Inc. | Compositions and methods for treating alpha-1 antitrypsin deficiency |
| US12594301B2 (en) | 2019-09-27 | 2026-04-07 | Beam Therapeutics Inc. | Compositions and methods for treatment of liquid cancers |
| AU2021347359A1 (en) | 2020-09-25 | 2023-05-18 | Beam Therapeutics Inc. | Fratricide resistant modified immune cells and methods of using the same |
| EP4458963A1 (en) * | 2023-05-04 | 2024-11-06 | Technische Universität Dresden | Highly active crispr base editors obtained through cas-assisted substrate-linked directed evolution (caslide) |
| WO2024227911A2 (en) * | 2023-05-04 | 2024-11-07 | Technische Universität Dresden | Highly active crispr base editors obtained through cas-assisted substrate-linked directed evolution (caslide) |
| CN120290534A (zh) * | 2024-01-10 | 2025-07-11 | 上海数因信科智能科技有限公司 | 腺嘌呤脱氨酶、包含其的碱基编辑器融合蛋白和碱基编辑器系统及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015332533B2 (en) * | 2014-10-14 | 2018-08-30 | Halozyme, Inc. | Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same |
| AU2020216484A1 (en) * | 2019-01-31 | 2021-07-29 | Beam Therapeutics Inc. | Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence |
| JP7646552B2 (ja) * | 2019-01-31 | 2025-03-17 | ビーム セラピューティクス インク. | 低減された非標的脱アミノ化を有する核酸塩基エディターおよび核酸塩基エディターの特徴づけのためのアッセイ |
| AU2020322021A1 (en) * | 2019-07-30 | 2022-02-10 | Pairwise Plants Services, Inc. | Morphogenic regulators and methods of using the same |
| US20220290121A1 (en) * | 2019-08-30 | 2022-09-15 | The General Hospital Corporation | Combinatorial Adenine and Cytosine DNA Base Editors |
| AU2020344547A1 (en) * | 2019-09-09 | 2022-03-24 | Beam Therapeutics Inc. | Novel nucleobase editors and methods of using same |
-
2022
- 2022-03-25 BR BR112023019539A patent/BR112023019539A2/pt unknown
- 2022-03-25 WO PCT/US2022/022050 patent/WO2022204574A1/en not_active Ceased
- 2022-03-25 CA CA3214494A patent/CA3214494A1/en active Pending
- 2022-03-25 EP EP22776767.0A patent/EP4313118A4/en active Pending
- 2022-03-25 JP JP2023558765A patent/JP2024511163A/ja active Pending
- 2022-03-25 AU AU2022246176A patent/AU2022246176A1/en active Pending
- 2022-03-25 KR KR1020237033780A patent/KR20240004276A/ko active Pending
-
2023
- 2023-09-26 US US18/474,969 patent/US20240158775A1/en active Pending